Novel Dibenzoazepine-Substituted Triazole Hybrids as Cholinesterase and Carbonic Anhydrase Inhibitors and Anticancer Agents: Synthesis, Characterization, Biological Evaluation, and <i>In Silico</i> Studies-Reference-Cited by-同舟云学术

Novel Dibenzoazepine-Substituted Triazole Hybrids as Cholinesterase and Carbonic Anhydrase Inhibitors and Anticancer Agents: Synthesis, Characterization, Biological Evaluation, and In Silico Studies

Published:2024-11-16 Issue:47 Volume:9 Page:46860-46878
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Erdoğan Musa¹,Onder Alper²^ORCID,Demir Yeliz³,Comert Onder Ferah⁴^ORCID

Affiliation:

1. Department of Food Engineering, Faculty of Engineering and Architecture, Kafkas University, 36100 Kars, Türkiye

2. Natural Products and Drug Research Laboratory, Department of Chemistry, Faculty of Science, Çanakkale Onsekiz Mart University, 17020 Çanakkale, Türkiye

3. Nihat Delibalta Gole Vocational High School, Department of Pharmacy Services, Ardahan University, 75700 Ardahan, Türkiye

4. Department of Medical Biology, Faculty of Medicine, Çanakkale Onsekiz Mart University, 17020 Çanakkale, Türkiye

Funder

Kafkas ?niversitesi

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.4c05804

Reference83 articles.

1. Design, synthesis, and biological activity of novel dithiocarbamate‐methylsulfonyl hybrids as carbonic anhydrase inhibitors

2. Carbonic anhydrase, obstructive sleep apnea and hypertension: Effects of intervention

3. Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase